ERBB2 and cancer: This phosphorylation has been shown to provide recognition sites for intracellular signaling intermediates, which link TZ-bound HER2 to inhibition of downstream transduction cascades that ultimately result in gene expression changes and inhibition of cancer cell proliferation15.